Výsledky vyhledávání - "C. Alex Wiles"

Safety and Efficacy of Vedolizumab Versus Tumor Necrosis Factor α Antagonists in an Elderly IBD Population: A Single Institution Retrospective Experience

Autor: Sara N. Horst, Robin Dalal, C. Alex Wiles, David A. Schwartz, Dawn B. Beaulieu, Elizabeth A. Scoville, James C. Slaughter, Baldeep S. Pabla

Publikováno v: Digestive Diseases and Sciences. 67:3129-3137

Vedolizumab is a monoclonal antibody used to treat inflammatory bowel disease (IBD). There is little known about the safety and comparative efficacy of this agent in the elderly population. Here, we present data on the safety and comparative efficacy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4f5facf3ace00a6784aa792696cfc7eb
https://doi.org/10.1007/s10620-021-07129-5

Zobrazit plný text záznamu

Tofacitinib Adherence and Outcomes in Refractory Inflammatory Bowel Disease

Autor: Nisha B Shah, Robin Dalal, Elizabeth A. Scoville, Jake Bell, Sara N. Horst, C. Alex Wiles, Dawn B. Beaulieu, Baldeep S. Pabla, David A. Schwartz

Publikováno v: Crohn's & Colitis 360. 3

Background Tofacitinib has been approved for moderate-to-severe ulcerative colitis and studied in Crohn’s disease. Understanding medication adherence to oral medications in severe disease is essential. Methods We retrospectively reviewed adherence

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ea1285201cbf85cdf3505847287fcb56
https://doi.org/10.1093/crocol/otab075

Zobrazit plný text záznamu

Safety and Efficacy of Vedolizumab Versus Tumor Necrosis Factor α Antagonists in an Elderly IBD Population: A Single Institution Retrospective Experience

Autor: Baldeep S, Pabla, C, Alex Wiles, James C, Slaughter, Elizabeth A, Scoville, Robin L, Dalal, Dawn B, Beaulieu, David A, Schwartz, Sara N, Horst

Publikováno v: Digestive diseases and sciences. 67(7)

Vedolizumab is a monoclonal antibody used to treat inflammatory bowel disease (IBD). There is little known about the safety and comparative efficacy of this agent in the elderly population.Here, we present data on the safety and comparative efficacy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f0d13f959f5128fe6825456fb2a32ec2
https://pubmed.ncbi.nlm.nih.gov/34268660

Zobrazit plný text záznamu

S0801 Tofacitinib Adherence and Outcomes in Patients With Refractory Ulcerative Colitis

Autor: Nisha Shah, Elizabeth A. Scoville, Baldeep S. Pabla, Sara N. Horst, Jacob Bell, David A. Schwartz, C. Alex Wiles, Dawn B. Beaulieu, Robin Dalal

Publikováno v: American Journal of Gastroenterology. 115:S411-S411

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a49daec07431d330b7090a6b51ea5c66
https://doi.org/10.14309/01.ajg.0000705252.01639.bf

Zobrazit plný text záznamu

S0800 Safety and Efficacy of Vedolizumab vs Tumor Necrosis Factor Antagonists in an Elderly IBD Population

Autor: Sara N. Horst, Dawn B. Beaulieu, Elizabeth A. Scoville, C. Alex Wiles, David A. Schwartz, Baldeep S. Pabla, Chris Slaughter, Robin Dalal

Publikováno v: American Journal of Gastroenterology. 115:S410-S410

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ba5e1c1d991847e14e928569654d7d28
https://doi.org/10.14309/01.ajg.0000705248.77205.de

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání